Page last updated: 2024-08-17

cycloserine and Extensively Drug-Resistant Tuberculosis

cycloserine has been researched along with Extensively Drug-Resistant Tuberculosis in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (62.50)24.3611
2020's3 (37.50)2.80

Authors

AuthorsStudies
Khanna, A; Pareek, PK; Raj, VS; Rattan, A; Saini, KS; Sharma, P; Singh, H; Sood, R; Tarai, B; Upadhyay, DJ1
André, P; Briki, M; Buclin, T; Burger, R; Choong, E; Cruchon, S; Da Silva Pereira Clara, JA; Decosterd, LA; Desfontaine, V; Kajkus, A; Koehler, N; Lange, C; Mazza-Stalder, J; Mercier, T; Opota, O; Sanchez Carballo, PM; Suttels, V1
Cho, HJ; Kang, MW; Kim, J; Koh, WJ; Lim, YJ; Song, CH1
Dhamija, RK; Garg, D; Saroha, D; Singh, AK1
Horsburgh, CR; Kvasnovsky, C; Master, I; O'Donnell, MR; Padayatchi, N; Werner, L1
Aggarwal, R; Nemade, P; Panjwani, T; Purohit, S1
Amiri, M; Baghaei, P; Caminero, JA; Chitsaz, E; Farnia, P; Kazempour, M; Mansouri, D; Marjani, M; Masjedi, MR; Shamaei, M; Tabarsi, P; Velayati, AA1
Freeman, JT; Goh, TL; Jones, KL; Towns, CR; Wong, CS1

Other Studies

8 other study(ies) available for cycloserine and Extensively Drug-Resistant Tuberculosis

ArticleYear
Emergence and molecular characterization of extensively drug-resistant Mycobacterium tuberculosis clinical isolates from the Delhi Region in India.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:11

    Topics: Amikacin; Antitubercular Agents; Bacterial Proteins; Capreomycin; DNA Gyrase; DNA Mutational Analysis; DNA-Directed RNA Polymerases; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; India; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Point Mutation; Polymerase Chain Reaction; Rifampin

2010
A battery of tandem mass spectrometry assays with stable isotope-dilution for the quantification of 15 anti-tuberculosis drugs and two metabolites in patients with susceptible-, multidrug-resistant- and extensively drug-resistant tuberculosis.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2022, Nov-15, Volume: 1211

    Topics: Antitubercular Agents; Cycloserine; Extensively Drug-Resistant Tuberculosis; Humans; Isoniazid; Isotopes; Mycobacterium tuberculosis; Tandem Mass Spectrometry; Tuberculosis, Multidrug-Resistant

2022
Different macrophage polarization between drug-susceptible and multidrug-resistant pulmonary tuberculosis.
    BMC infectious diseases, 2020, Jan-29, Volume: 20, Issue:1

    Topics: Adult; Antitubercular Agents; Cycloserine; Extensively Drug-Resistant Tuberculosis; Female; Humans; Lung; Macrophage Activation; Macrophages; Male; Middle Aged; Mycobacterium tuberculosis; Prothionamide; Pyrazinamide; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2020
Irreversible neuropathy in extremely-drug resistant tuberculosis: An unfortunate clinical conundrum.
    The Indian journal of tuberculosis, 2020, Volume: 67, Issue:3

    Topics: Adult; Aminosalicylic Acid; Antitubercular Agents; Clofazimine; Cycloserine; Deprescriptions; Diarylquinolines; Ethionamide; Extensively Drug-Resistant Tuberculosis; Female; Humans; Kanamycin; Linezolid; Neural Conduction; Neurotoxicity Syndromes; Peripheral Nervous System Diseases; Pyrazinamide; Pyridoxine; Tuberculosis, Pulmonary

2020
Treatment outcomes for extensively drug-resistant tuberculosis and HIV co-infection.
    Emerging infectious diseases, 2013, Volume: 19, Issue:3

    Topics: Adolescent; Adult; Antitubercular Agents; Coinfection; Cycloserine; Drug Therapy, Combination; Ethambutol; Ethionamide; Extensively Drug-Resistant Tuberculosis; Female; HIV Infections; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult

2013
XDR TB presenting as a transphyseal lytic lesion in the proximal tibia.
    BMJ case reports, 2015, Aug-11, Volume: 2015

    Topics: Antitubercular Agents; Child, Preschool; Clofazimine; Cycloserine; Extensively Drug-Resistant Tuberculosis; Humans; Kanamycin; Tibia; Tuberculosis, Osteoarticular

2015
Impact of extensively drug-resistant tuberculosis on treatment outcome of multidrug-resistant tuberculosis patients with standardized regimen: report from Iran.
    Microbial drug resistance (Larchmont, N.Y.), 2010, Volume: 16, Issue:1

    Topics: Adult; Amikacin; Anti-Bacterial Agents; Clinical Protocols; Cycloserine; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Female; Humans; Iran; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Prothionamide; Treatment Outcome; Tuberculosis, Pulmonary

2010
Extensively drug-resistant tuberculosis: New Zealand's first case and the challenges of management in a low-prevalence country.
    The Medical journal of Australia, 2011, Jun-06, Volume: 194, Issue:11

    Topics: Acetamides; Adult; Aminosalicylic Acid; Antitubercular Agents; Aza Compounds; Cycloserine; Emigrants and Immigrants; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; Imipenem; Linezolid; Lymph Nodes; Male; Moxifloxacin; Myanmar; New Zealand; Oxazolidinones; Quinolines; Radiography

2011